angiotensin ii has been researched along with Prostatic Hyperplasia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avetyan, AV; Chernogubova, EA; Chibichyan, MB; Kogan, MI; Lapteva, TO; Pavlenko, IA | 1 |
| Dua, K; Gupta, G; Matta, Y; Mishra, A; Pinto, TJA; Sharma, R; Singh, Y | 1 |
| Dong, L; Qu, X; Shen, F; Zhang, X; Zhao, X | 1 |
| Dong, LN; Qu, XB; Shen, F; Zeng, XF; Zhang, XY; Zhao, XK | 1 |
| Wyllie, M | 1 |
| Aumüller, G; Wennemuth, G | 1 |
| Guo, YL; Jin, J; Yu, W; Zhang, ZW; Zhao, YY | 1 |
| Casely, D; Catt, KJ; Chow, L; Frauman, AG; Imamura, K; Louis, SN; Louis, WJ; MacGregor, DP; Rezmann, LA; Wang, L | 1 |
| Fabiani, ME; Frauman, AG; Johnston, CI; Sourial, M; Thomas, WG | 1 |
| Casley, DJ; Dinh, DT; Fabiani, ME; Frauman, AG; Johnston, CI; Ohishi, M; Somers, GR; Zhou, J | 1 |
1 review(s) available for angiotensin ii and Prostatic Hyperplasia
| Article | Year |
|---|---|
Embarking Effect of ACE2-Angiotensin 1-7/Mas Receptor Axis in Benign Prostate Hyperplasia.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Prostatic Hyperplasia; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2018 |
9 other study(ies) available for angiotensin ii and Prostatic Hyperplasia
| Article | Year |
|---|---|
[The role of angiotensin-converting enzyme and angiotensin ii receptors of the second type in the pathogenesis of proliferative diseases of the prostate].
Topics: Angiotensin II; Humans; Male; Peptidyl-Dipeptidase A; Prostatic Hyperplasia; Prostatic Neoplasms; Renin-Angiotensin System | 2022 |
Influence and pathophysiological mechanisms of simvastatin on prostatic hyperplasia in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Endoplasmic Reticulum; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Inflammation; Insulin-Like Growth Factor I; Interleukin-6; Male; Mitochondria; Nitric Oxide Synthase Type III; Prostatic Hyperplasia; Rats; Rats, Inbred SHR; Simvastatin | 2013 |
[Inhibitory effect of losartan on prostatic hyperplasia in spontaneous hypertension rats and its pathophysiological mechanism].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Hypertension; Insulin-Like Growth Factor I; Interleukin-6; Losartan; Male; Nitric Oxide Synthase Type III; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred SHR | 2012 |
Two for the price of one?
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Agonists; Angiotensin II; Apoptosis; Azasteroids; Cell Line; Cell Proliferation; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Mitogens; Prostatic Hyperplasia; Receptor, Angiotensin, Type 1; Stromal Cells | 2005 |
Angiotensin II-mediated calcium signals and mitogenesis in human prostate stromal cell line hPCPs.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Buffers; Calcium; Calcium Signaling; Cell Line; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Fluorescent Dyes; Fura-2; Humans; Immunohistochemistry; Intracellular Fluid; Isotonic Solutions; Losartan; Male; Mitosis; Photometry; Prostatic Hyperplasia; Receptor, Angiotensin, Type 1; Ringer's Solution; Stromal Cells; Time Factors | 2005 |
Angiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-beta1 in prostate tissue of spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; bcl-2-Associated X Protein; Blotting, Western; Losartan; Male; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transforming Growth Factor beta1 | 2007 |
Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate.
Topics: Aged; Angiotensin II; Biomarkers, Tumor; Blotting, Western; Cell Transformation, Neoplastic; Epithelial Cells; Humans; Immunohistochemistry; Male; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2007 |
Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Norepinephrine; Oligopeptides; Prostate; Prostatic Hyperplasia; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sympathetic Nervous System; Synaptic Transmission | 2001 |
Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia.
Topics: Angiotensin I; Angiotensin II; Case-Control Studies; Epithelium; Humans; Immunohistochemistry; Male; Muscle, Smooth, Vascular; Prostate; Prostatic Hyperplasia; Receptors, Angiotensin; Renin-Angiotensin System | 2002 |